Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 100%Moderate 0 · 0%High 0 · 0%

All adverse events · people with confirmed COVID‐19

Favipiravir may leads to higher all adverse events compared with no treatment, supportive treatment, or other antiviral treatment (low certainty).

1 finding from 1 review

Favipiravir for treating COVID‐19 2024 · Cochrane Headline outcomes only
RR 1.27 [1.05, 1.54]
18 studies · 4699 participants
Low